The elevation of CF6 in MCT-induced PAH led us to hypothesize that CF6 might be an initiating factor for PAH, and that blocking CF6 peptide using recombinant AAV-2 carrying the rat CF6 short hairpin small-interfering RNA could prevent development of PAH. The gene discussed is ATP5PF; the disease is pulmonary arterial hypertension.